Abstract
This chapter will describe the use of the immunoblotting method for analysing antibody specificities towards meningococcal antigens in sera from vaccinees, receiving group B meningococcal outer-membrane vesicle (OMV) vaccines, or from patients, falling ill with meningococcal disease. The power of the blotting technique lies in the simultaneous identification of many immunogenic components in a sample. Within the meningococcal field, this method has been employed in analyzes of antibody specificities of sera from vaccinees (1–6), patients (7–10), and carriers (11,12) as well as for characterization of OMV vaccines (13,14). Some of these studies present various ways of quantifying the blotting results (5,7,9,11).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Boslego, J., Garcia, J., Cruz, C., Zollinger, W., Brandt, B., Ruiz, S., et al., and the Chilean National Committee for Meningococcal Disease. (1995) Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Vaccine 9, 821–829.
Milagres, L. G., Ramos, S. R., Sacchi, C. T., Melles, C. A. E., Vieira, V. S. D., Sato, H., et al. (1994) Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy. Infect. Immun. 62, 4419–4424.
Peeters, C. C. A. M., Rümke, H. C., Sunderman, L. C., Rouppe van der Voort, E. M., Meulenbelt, J., Schuller, M., et al. (1996) Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine. Vaccine 14, 1009–1015.
Rosenqvist, E., Høiby, E. A., Wedege, E., Kusceck, B., and Achtman, M. (1993) The 5C protein of Neisseria meningitidis is highly immunogenic in humans and induces bactericidal antibodies. J. Infect. Dis. 167, 1065–1073.
Rosenqvist, E., Høiby, E. A., Wedege, E., Bryn, K., Kolberg, J., Klem, A., et al. (1995) Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine. Infect. Immun. 63, 4642–4652.
Wedege, E. and Frøholm., L. O. (1986) Human antibody response to a group B serotype 2a meningococcal vaccine determined by immunoblotting. Infect. Immun. 51, 571–578.
Idänpään-Heikkilä, I., Høiby, E. A., Chattopadhyay, P., Airaksinen, U., Michaelsen, T. E., and Wedege, E. (1995) Antibodies to meningococcal class 1 outer-membrane protein and its variable regions in patients with systemic meningococcal disease. J. Med. Microbiol. 43, 335–343.
Mæland, J. A. and Wedege, E. (1989) Serum antibodies to cross-reactive Neisseria outer membrane antigens in healthy persons and patients with meningococcal disease. APMIS 97, 774–780.
Wedege, E., Høiby, E. A., Rosenqvist, E., and Bjune, G. (1998) Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial. Infect. Immun. 66, 3223–3231.
Zollinger, W. D., Boslego, J. W., Moran, E. E., Brandt, B. L., Cruz, C., Martinez, M., and Garcia, J. (1994) Effect of vaccination with meningococcal outer membrane protein vaccine on subsequent antibody reponses to carriage and natural infections, in Pathobiology and Immunobiology of Neisseriaceae (Conde-Glez, C. J., Morse, S., Rice, P., Sparling, R., and Calderon, E., eds.), Instituto Nacional de Salud Publica. Cuernavaca, Morelos, Mexico, pp. 954–960.
Jones, G. R., Christodoulides, M., Brooks, J. L., Miller, A. R. O., Cartwright, K. A. V., and Heckels, J. E. (1998) Dynamics of carriage of Neisseria meningitidis in a group of military recruits: Subtype stability and specificity of the immune response following colonization. J. Infect. Dis. 178, 451–459.
Woods, J. P. and Cannon, J. G. (1990) Variation in expression of class 1 and class 5 outer membrane proteins during nasopharyngeal carriage of Neisseria meningitidis. Infect. Immun. 58, 569–572.
Fredriksen, J. H., Rosenqvist, E., Wedege, E., Bryn, K., Bjune, G., Frøholm, L. O., et al. (1991) Production, characterization and control of MenB-vaccine “Folkehelsa”: an outer membrane vesicle vaccine against group B meningococcal disease. NIPH Ann. 14, 67–80.
van der Ley, P., van der Biezen, J., and Poolman, J. T. (1995) Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle vaccine. Vaccine 13, 401–407.
Waehneldt, T. V. (1975) Sodium dodecyl sulfate in protein chemistry. BioSystems 6, 176–187.
Shapiro, A. L., Vinuela, E., and Maizel, J. V., Jr. (1967) Molecular weight estimation of polypeptide chains by electrophoresis in SDS-polyacrylamide gels. Biochem. Biophys. Res. Comm. 28, 815–820.
Gershoni, J. M. and Palade, G. E. (1983) Protein blotting: Principles and applications. Anal. Biochem. 131, 1–15.
Towbin, H., Staehelin, T., and Gordon, J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedures and some applications. Proc. Natl. Acad. Sci. USA 76, 4350–4354.
Burnette, W. N. (1981) “Western blotting”: Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated Protein A. Anal. Biochem. 112, 195–203.
Beisiegel, U. (1986) Protein blotting. Electrophoresis 7, 1–18.
Huisman, J. G. (1986) Immunoblotting: An emerging technique in immunohematology. Vox Sang. 50, 129–136.
Gershoni, J. M. (1988) Protein blotting: a manual, in Methods of Biochemical Analysis, vol 33 (Glick, D., ed.), John Wiley and Sons, New York, pp. 1–58.
Stott, D. I. (1989) Immunoblotting and dot blotting. J. Immunol. Methods 119, 153–187.
Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680–685.
Mandrell, R. E. and Zollinger, W. D. (1984) Use of a zwitterionic detergent for the restoration of the antibody-binding capacity of electroblotted meningococcal outer membrane proteins. J. Immunol. Methods 67, 1–11.
Wedege, E., Bryn, K., and Frøholm, L. O. (1988) Restoration of antibody binding to blotted meningococcal outer membrane proteins using various detergents. J. Immunol. Methods 113, 51–59.
Wedege, E., Bolstad, K., Wetzler, L. M., and Guttormsen, H. K. (2000) IgG antibody levels to meningococcal porins in patient sera: comparison of immunoblotting and ELISA measurements. J. Immunol. Methods 244, 9–15.
Nicolas, R. H., and Goodwin, G. H. (1982) Isolation and analysis, in The HMG Chromosomal Proteins (Johns, E. W., ed.), Academic Press, London, pp. 41–68.
Frasch, C. E. and Mocca, L. F. (1978) Heat-modifiable outer membrane antigens of Neisseria meningitidis and their organization within the membrane. J. Bacteriol. 136, 1127–1134.
Abdillahi, H., Crowe, B. A., Achtman, M., and Poolman, J. T. (1988) Two monoclonal antibodies specific for serotype-4 antigen of Neisseria meningitidis. Eur. J. Clin. Microbiol. Infect. Dis. 7, 293–296.
Gershoni, J. M. and Palade, G. E. (1982) Electrophoretic transfer of proteins from sodium-dodecyl-sulfate-polyacrylamide gels to a positively charged membrane filter. Anal. Biochem. 124, 396–405.
Chavez, L. G. and Benjamin, D. G. (1978) Antibody as an immunological probe for studying the refolding of bovine serum albumin. J. Biol. Chem. 253, 8081–8086.
Carlson, J. D. and Yarmush, M. L. (1992) Antibody assisted protein refolding. Biotechnology 10, 86–91.
Tomáska, L. and Nosek, J. (1995) Several polymers enhance the sensitivity of the Southwestern assay. Anal. Biochem. 227, 387–389.
Rittenhouse, J. and Marcus, F. (1984) Peptide mapping by polyacrylamide gel electrophoresis after cleavage at aspartyl-prolyl bonds in sodium dodecyl sulfate-containing buffers. Anal. Biochem. 138, 442–448.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Wedege, E. (2001). Immunoblot Analysis of Sera from Patients and Vaccinees. In: Pollard, A.J., Maiden, M.C. (eds) Meningococcal Vaccines. Methods in Molecular Medicine™, vol 66. Humana Press. https://doi.org/10.1385/1-59259-148-5:275
Download citation
DOI: https://doi.org/10.1385/1-59259-148-5:275
Publisher Name: Humana Press
Print ISBN: 978-0-89603-801-1
Online ISBN: 978-1-59259-148-0
eBook Packages: Springer Protocols